Hansoh Pharmaceutical Group Company

Traded on the St. Petersburg Stock Exchange
Hansoh Pharmaceutical is a leading biopharmaceutical company in Asia, committed to improving human health through continuous innovation, with more than 10,000 employees in China and the United States
Hansoh Pharmaceutical Group Company stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Hansoh Pharmaceutical Group Company balance sheet

Report period2018 2019 2020 2021 2022 2023
End date of the reporting period
Capitalization, CN¥
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Hansoh Pharmaceutical Group Company cash flows

Report period2018 2019 2020 2021 2022 2023
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Hansoh Pharmaceutical Group Company multipliers

Report period2018 2019 2020 2021 2022 2023
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Hansoh Pharmaceutical Group Company profitability

Report period2018 2019 2020 2021 2022 2023
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Hansoh Pharmaceutical Group Company assets
Hansoh Pharmaceutical Group Company cash flows
Hansoh Pharmaceutical Group Company dividends
0%

Hansoh Pharmaceutical Group Company dividend policy

The company pays dividends once every six months

Hansoh Pharmaceutical Group Company shares

TickerNameTypeNominal valueISINPrice
3692:HKHansoh Pharmaceutical Group CompanyCommon share-KYG549581067CN¥11.86
General information
Company nameHansoh Pharmaceutical Group Company
Tags#hong_kong_spb
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business address287 Xiangke Road, Pudong New District, Shanghai, China
Websitewww.hspharm.com